Saturday, 6 July 2013

Hope For An Injectable Antidote Suitable For Treatment Of Cyanide Victims In A Mass Casualty Setting

Main Category: Bio-terrorism / Terrorism
Article Date: 04 Feb 2013 - 0:00 PST Current ratings for:
Hope For An Injectable Antidote Suitable For Treatment Of Cyanide Victims In A Mass Casualty Setting
not yet ratednot yet rated
In an advance toward closing a major gap in defenses against terrorist attacks and other mass casualty events, scientists are reporting discovery of a promising substance that could be the basis for development of a better antidote for cyanide poisoning. Their report, which describes a potential antidote that could be self-administered, much like the medication delivered by allergy injection pens, appears in ACS' Journal of Medicinal Chemistry.

Steven E. Patterson, Ph.D., and colleagues at the University of Minnesota Center for Drug Design explain that the only existing antidotes for cyanide - recognized as a high-risk substance for potential use by terrorists - must be administered by intravenous infusion. That procedure requires highly trained paramedical personnel and takes time. Cyanide, however, is a fast-acting poison. In a situation involving mass casualties, only a limited number of victims could be saved. Patterson's team thus sought an antidote that could be administered by intra-muscular (IM) injection, a simpler procedure that could be administered rapidly to a large number of victims or even be self-administered.

Their report describes discovery of a substance, sulfanegen TEA, "which should be amenable for development as an IM injectable antidote suitable for treatment of cyanide victims in a mass casualty setting. Further development, including efficacy in lethal cyanide animal models, will be reported at a later date."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our bio-terrorism / terrorism section for the latest news on this subject. The authors acknowledge financial support from the National Institutes of Health through the National Institute of Neurological Disorders and Stroke (award #UO1NS058087-05).
American Chemical Society Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Chemical Society. "Hope For An Injectable Antidote Suitable For Treatment Of Cyanide Victims In A Mass Casualty Setting." Medical News Today. MediLexicon, Intl., 4 Feb. 2013. Web.
5 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Hope For An Injectable Antidote Suitable For Treatment Of Cyanide Victims In A Mass Casualty Setting'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

No comments:

Post a Comment